Regarding systemic lupus erythematosus (SLE), anti-TNF therapy is rarely used due to the potential induction of lupus-like syndromes, although etanercept has occasionally been employed with some success for refractory arthritis in clinical observational studies [220]. This evidence concerns the gene TNF and systemic lupus erythematosus.